UNC-Chapel Hill researchers received an $11.3 million grant to conduct studies on the use of nanoparticles to create cancer vaccines and improve cancer drug delivery.
The grant, announced Monday, will fund work during the next five years by researchers with the Carolina Center of Cancer Nanotechnology Excellence (CCCNE), a collaboration between UNC and the UNC Lineberger Comprehensive Cancer Center. It is the third in a series of awards that the university has won from the National Cancer Institute for cancer nanotechnology research.
The grant will fund four different studies into the use of nanotechnology to fight cancer.
The first will look at a vaccine that would train the body’s immune system to fight drug-resistant melanoma. The second will involve using nanoparticles to develop a vaccine for advanced melanoma. The third will use nanotechnology and radiation therapy to try to improve patient responses to certain cancer drugs. In the final project, researchers will use a capsule made using nanoparticles to load and deliver cancer drugs.